The global Patient Engagement Platforms Market Share was valued at USD 16.6 billion in 2021 and is expected to grow at a CAGR of 17% during the forecast period, reaching US$ 93.4 Bn by 2032.
Factors driving the patient engagement platforms market share include favorable government laws and activities to promote the adoption of HCIT solutions, the benefits of patient rounding solutions, and the growing number of stakeholder alliances and partnerships.
However, constraints such as costly IT infrastructure investments and a dearth of trained IT workers in the healthcare industry are projected to limit the demand for patient engagement platforms to some extent over the forecast period.
Government policies and activities that encourage the adoption of HCIT solutions are driving the sales of patient engagement platforms forward.
The rising demand for high-quality treatment has driven healthcare systems around the world to implement cutting-edge technology that assists cut costs, improving care quality, and eliminating administrative inefficiencies. This guarantees that all hospitals have access to better patient experience platforms.
Attain a visually compelling report with accompanying graphs and charts. @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14398
The HITECH Act formed ONC and gave the US Department of Health and Human Services the authority to create initiatives to promote health IT and improve healthcare quality, safety, and efficiency. The usage of patient experience technology solutions is likely to increase as a result of such activities.
The majority of healthcare organizations engaged in patient engagement in healthcare lack the necessary infrastructure (technology, data, and other resources) to implement complex HCIT solutions.
Providers must make additional expenditures in infrastructure development to support IT systems in order to properly integrate patient experience technology solutions.
Owing to the efficiency of a patient experience technology solution is determined by the hardware and software available to the end-user, any end-user interested in implementing one must first invest extensively in these areas. Many hospitals have limited funds; such large investments are difficult for them to make.
Patient engagement platforms market adoption is on the rise as a result of factors such as the rising prevalence of chronic diseases and the growing geriatric population.
According to the American Diabetes Association 2020, 1.5 million new cases of diabetes are diagnosed in the United States each year. Companies are focused on the development of patient engagement solutions in response to the rising number of diabetic patients.
Empower Your Decision-Making with Insights from Experts. @ https://www.futuremarketinsights.com/ask-question/rep-gb-14398
Data security issues are extremely critical in the digital patient engagement platforms since the infrastructure can be exposed to networks that are not part of the organization’s secure network.
Medical devices connected to home networks, public Wi-Fi, or cellular networks, for example, may broadcast information back to the hospital’s network. These external networks may not be secure, allowing unwanted access to the data being exchanged. As a result, patient comments may be shared with unintended recipients, which could be exploited and lead to a security breach.
Key Takeaways
- In 2026, the market for patient experience technology in the United States is predicted to be worth $299 million.
- With a revenue share of over 75.0 per cent in 2021, the web and cloud-based category dominated the market. These solutions are becoming more popular as a result of remote access to real-time data tracking, integrated features, easy accessibility, low handling costs, and simple data backup.
- In 2020, the technology category impacted the majority of the patient experience technology and patient engagement platforms market outlook in the United States. Technology is an essential aspect of the patient experience journey, and it is expected to increase at the fastest CAGR during the projection period.
- In 2021, the software and hardware sector had the greatest patient engagement platforms market share of more than 60.0 per cent, and it is predicted to grow at the quickest CAGR over the forecast period.
- As the key component of every patient engagement solution, communication accounted for the greatest patient engagement platforms market share of approximately 35.0 per cent in 2021. A spike in demand and implementation of telehealth, mhealth, and other virtual communication options via audio, video, and text is responsible for this huge proportion.
- Due to the presence of significant players, increased acceptance of mhealth and EHR, and expanding investment in patient engagement software by big enterprises, North America held the largest revenue share of about 35.0 per cent in 2021.
Be a game-changer with a customized and impactful report. Request for Customization.@ https://www.futuremarketinsights.com/customization-available/rep-gb-14398
“During the forecasted period, the Asia Pacific patient engagement platforms market is predicted to grow at an attractive rate of 18.8%. The growth of this region is aided by the economic prosperity of countries such as India and China.”
Competitive Landscape
Due to the presence of large and small enterprises, the demand for patient engagement platforms has been characterized by severe rivalry. A considerable portion of the market is controlled by key players. To increase their market presence, major firms are pursuing new strategies such as geographic penetration, new product/solution development, mergers and acquisitions, partnerships, and strategic alliances.
Some prominent patient engagement platform vendors in the global patient engagement platforms market include NextGen Healthcare, Inc., CPSI, McKesson Corporation, Allscripts Healthcare, LLC, Experian Information Solutions, Inc., ResMed, Epic Systems Corporation, Klara Technologies, Inc., Koninklijke Philips N.V., and Cerner Corporation.
- Press Ganey (US) collaborated with The Beryl Institute (US) in 2021, a global network of healthcare professionals and seasoned champions. Press Ganey will focus on expanding the healthcare experience movement as a result of this partnership.
- Vocera (US) and Amazon (US) cooperated in 2021 to create the Vocera Skill tool for Alexa. Vocera Skill will add hands-free and immersive voice experiences for patients and their families to Vocera’s ecosystem.
- SONIFI Health (US) and CipherHealth (US) formed a strategic agreement in 2021 to combine their primary strengths and give health systems a more comprehensive approach to patient communication and successful care planning.
Key Segments
By Component:
- Technology
- Patient Rounding
- Patient Experience Survey
- Consulting Services
By Facility Type:
- Acute Care Facility
- Acute Hospitals
- Children’s Hospitals
- Academic Medical Centre
- Military Treatment Facility
- Ambulatory Surgery Centre
- Post Acute Care Facility
- Long Term Acute Facility
- Skilled Nursing Facility
- Other
- Non Acute Care Facility
- Physicians Office
- Clinics
Uncover More Information by Clicking on the Provided Link Buy This Report. @ https://www.futuremarketinsights.com/checkout/14398
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:
Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.
Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.
Sepsis Diagnostics Market: The global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
